Details of the Drug

General Information of Drug (ID: DM3LWFJ)

Drug Name

NVX-108

Synonyms

Dodecafluoropentane; PERFLUOROPENTANE; 678-26-2; Pentane, dodecafluoro-; Perfluoro-n-pentane; Perfuoro-n-pentane; Flutec PP50; n-Perfluoropentane; UNII-483AU1Y5CZ; EINECS 211-647-5; BRN 1712388; 483AU1Y5CZ; CHEBI:39428; NJCBUSHGCBERSK-UHFFFAOYSA-N; R 41(12); NCGC00167420-01; 1,1,1,2,2,3,3,4,4,5,5,5-Dodecafluoropentane; Pentane,1,1,1,2,2,3,3,4,4,5,5,5-dodecafluoro-; Pentane, 1,1,1,2,2,3,3,4,4,5,5,5-dodecafluoro-; Perflenapent [USAN]; Perflenapent [USAN:INN]; perflenapentum; Fluorinert FC 87; fluorinertr(fc-87); dodecaf

Indication

Disease Entry	ICD 11	Status	REF
Recurrent glioblastoma	2A00.00	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C5F12
Canonical SMILES: C(C(C(F)(F)F)(F)F)(C(C(F)(F)F)(F)F)(F)F
InChI: 1S/C5F12/c6-1(7,2(8,9)4(12,13)14)3(10,11)5(15,16)17
InChIKey: NJCBUSHGCBERSK-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 12675
ChEBI ID: CHEBI:39428
CAS Number: 678-26-2
UNII: 483AU1Y5CZ
DrugBank ID: DB11625
TTD ID: D03XAO

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)